Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
Status:
Active, not recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This study is a Japanese post-marketing surveillance (PMS) which is required by the
regulatory authorities. General objective of PMS is to confirm the clinical usefulness,
especially the safety profile of a drug under the routine clinical practice.